GNH USA

Europe — EMA

Nitroglycerine Hameln (Glyceryl Trinitrate)

GNH USA supplies Nitroglycerine Hameln (Glyceryl Trinitrate), a nitrate vasodilator for acute angina, heart failure and hypertensive emergencies.

Request sourcing

1
Pack/s

What is Glyceryl Trinitrate?

Glyceryl trinitrate, the active ingredient in Nitroglycerine Hameln, is a nitrate vasodilator presented as an intravenous solution for intravenous use. It provides rapid vasodilation and is employed in the acute management of angina pectoris, decompensated heart failure, and hypertensive emergencies, typically in hospital settings under physician supervision.

GNH USA supplies Nitroglycerine Hameln as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and procurement teams worldwide, with quality‑assured manufacturing meeting EU standards. The company ensures regulatory compliance and reliable cold‑chain logistics where required.

What is Glyceryl Trinitrate used for?

Nitroglycerine Hameln (glyceryl trinitrate) is used in the nitrate vasodilator pathway to relieve myocardial ischemia and reduce cardiac workload. - Acute angina pectoris: rapid relief of chest pain by dilating coronary arteries and reducing myocardial oxygen demand. - Acute decompensated heart failure: improves cardiac output by decreasing preload and afterload. - Hypertensive emergencies: lowers blood pressure quickly through systemic vasodilation.

What are the side effects of Glyceryl Trinitrate?

Glyceryl trinitrate may cause a range of adverse reactions, varying from mild to severe. Common Side Effects: - Headache: throbbing headache due to cerebral vasodilation. - Flushing: warm sensation and skin redness. - Hypotension: drop in blood pressure, especially with rapid infusion. Serious or Rare Side Effects: - Methemoglobinemia: elevated methemoglobin causing cyanosis. - Severe hypotension: profound blood pressure fall leading to syncope. - Allergic reaction: rash, itching, or anaphylaxis.

What precautions apply to Glyceryl Trinitrate?

When using Nitroglycerine Hameln, several precautions should be observed to minimize risk and ensure efficacy. - Monitor blood pressure: check systolic and diastolic values before and during infusion. - Assess tolerance: avoid continuous exposure to prevent tachyphylaxis. - Use with caution in hypovolemia: low circulating volume can exacerbate hypotension. - Contraindicated with phosphodiesterase‑5 inhibitors: concurrent use may cause severe hypotension. - Adjust dose in elderly: start with lower infusion rates and titrate carefully. - Store at controlled room temperature: keep below 25°C, protect from light and moisture, and retain in original container.

What does Glyceryl Trinitrate interact with?

Glyceryl trinitrate interacts with several medicines; awareness of these interactions helps avoid adverse events. Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): can cause profound hypotension. - Other nitrates (e.g., isosorbide dinitrate): additive vasodilatory effect leading to severe blood pressure drop. - Guanylate cyclase stimulators: may amplify cGMP‑mediated vasodilation. Moderate Interactions (Monitor Closely): - Antihypertensives (beta‑blockers, ACE inhibitors): may enhance blood pressure lowering. - Diuretics: can increase risk of hypotension due to volume depletion. - Alcohol: may potentiate vasodilatory effects and dizziness.

Frequently asked questions

What conditions is Nitroglycerine Hameln used to treat?+
Nitroglycerine Hameln, containing glyceryl trinitrate, is indicated for the rapid relief of acute angina pectoris, for the management of acute decompensated heart failure, and for the control of hypertensive emergencies. In each case the drug is administered intravenously in a hospital setting to achieve prompt vasodilation and reduction of cardiac workload.
How does glyceryl trinitrate work in the body?+
Glyceryl trinitrate acts as a donor of nitric oxide. After intravenous administration it is converted to nitric oxide, which stimulates soluble guanylate cyclase in vascular smooth‑muscle cells. The resulting rise in cyclic GMP causes relaxation of both venous and arterial smooth muscle, producing vasodilation, lowering preload and afterload, and decreasing myocardial oxygen demand.
What is the usual dose of Nitroglycerine Hameln?+
The dosing regimen for Nitroglycerine Hameln is determined by the treating physician based on the patient’s clinical status, severity of symptoms, and response to therapy. The prescriber selects the infusion rate and duration, and adjustments are made according to continuous monitoring of blood pressure and heart rate.
Is Nitroglycerine Hameln safe to use during pregnancy or breastfeeding?+
Safety data for glyceryl trinitrate in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. It should be used only if the potential benefit justifies the potential risk to the fetus, and breastfeeding mothers should consult a healthcare professional before use.
How do I order Nitroglycerine Hameln from GNH USA?+
To order Nitroglycerine Hameln, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where applicable) and the necessary import documentation.
How does Nitroglycerine Hameln compare with other nitrate drugs?+
Nitroglycerine Hameln delivers glyceryl trinitrate intravenously, offering rapid onset of action suitable for emergency settings, whereas oral nitrates such as isosorbide dinitrate have a slower onset and are used for chronic angina prophylaxis. Intravenous nitroglycerin provides precise titration and immediate blood pressure control, but requires continuous monitoring, while oral agents are more convenient for long‑term outpatient use.
What are the storage and handling requirements for Nitroglycerine Hameln?+
Nitroglycerine Hameln should be stored at controlled room temperature, preferably below 25 °C. Keep the vials in their original packaging, protect them from light, moisture and extreme temperature fluctuations, and avoid freezing. Handling should be performed by trained personnel using aseptic technique to maintain sterility of the intravenous solution.
How is Nitroglycerine Hameln administered?+
The product is supplied as a sterile intravenous solution that is administered by a healthcare professional through a peripheral or central venous line. The infusion rate is titrated to achieve the desired hemodynamic effect, with continuous monitoring of blood pressure, heart rate and clinical response throughout the administration.
What are the most serious risks associated with Nitroglycerine Hameln?+
The most serious adverse events to watch for are profound hypotension that can lead to syncope, methemoglobinemia which may cause cyanosis and impaired oxygen delivery, and severe allergic reactions including anaphylaxis. Immediate medical intervention is required if any of these events occur, and infusion should be stopped promptly.
Who should not use Nitroglycerine Hameln?+
Nitroglycerine Hameln is contraindicated in patients who are receiving phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil) due to the risk of severe hypotension, in those with known hypersensitivity to nitrates, and in patients with severe anemia or increased intracranial pressure. It should also be used with caution in patients with recent myocardial infarction or unstable hemodynamics.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Glyceryl Trinitrate
Route
Intravenous Use
Manufacturer
Hameln Pharma Gmbh
Origin
EU

Related products